CARDIAC ELECTROPHYSIOLOGICAL INDICES AND PEPTIDE MOLECULAR-MASS DISTRIBUTION IN BLOOD SERUM OF RATS WITH EXPERIMENTAL MYOCARDIAL INFARCTION

Chizh M. O., Galchenko S. Ye.

CLINICAL AND EXPERIMENTAL MEDICINE

Scentific article

Recent studies demonstrate an increasing interest to cardio-vascular biomarkers with assessing the risk in heart ischemic disease. Along with cardiac electrophysiological indices the molecular-mass distribution of peptides appears as one of novel markers of the risk of cardiovascular complications, since they indicate the effect on developing unfavorable cardiovascular events. Fluorescent probes are also applied for diagnosis and forecasting the developing diseases, revealing the risk factors and control of the treatment efficiency. Research aim was to analyze the changes in electrophysiological indices of heart, molecular-mass distribution of peptides in blood serum and albumin loading with ligands during developing necrosis and remodeling of heart with experimental infarction in rats. Research object and methods. Experiments were performed in 30 outbred male rats of 180-250 g weight under inhalation anestheticon spontaneous breath under the regulations approved by the Bioethics Committee of the IPC&С of the National Academy of Sciences of Ukraine. Myocardial necrosis was simulated by left anterior descending coronary artery ligation. Electrocardiograms (ECG) were recorded with digital ECG Poly-Spectrum 8/B system (Neorsoft, Russia). To determine the molecular weight distribution of low molecular weight fractions of peptide nature, the method of highly effective gel permeation chromatography was used. Fluorescence probes K-35 and E-176, synthesized at State Scientific Institution “Institute for Single Crystals” of the National Academy of Sciences of Ukraine (Kharkiv) was used the studies. The fluorescence spectra were recorded with a Cary Eclipse spectrometry (Varian, Australia). Microcal Origin 6.0 was used to process and visualize the spectra. Experimental studies were performed at days 1, 7, 14 and 30. The results were statistically processed with Kruskal-Wallis criterion using the STATISTICA 6.0 software (StatSoft, USA).Results. During the entire observation period, the electrocardiographic indices noted a change in the phases of the development of an experimental myocardial infarction and the processes of remodeling of the cardiac tissue of anterior-lateral parts of the heart. According to the analysis of the chromatogram of rat serum peptides, it was found that in an acute phase of myocardial infarction, the changes in molecular weight distribution in an acute phase of myocardial infarction were observed, which was reflected by a decrease of peak in the region of macromolecular peptides with m.w.> 10,000 from 61.5% to 3.3%, and the appearance of peaks in the region of low molecular weight peptides within the range of m.w. 290-527. Reducing the fluorescence intensity of probes in one day after the simulation of myocardial infarction indicates an increase in the loading of albumin by ligands. Conclusions. Characteristic peptide molecular-mass distribution in blood serum and albumin loading with ligands for each stage of myocardium necrosis development and its remodeling in experimental myocardium infarction has been shown.

myocardial infarction, electrocardiography, blood serum, peptides, fluorescent probes

1. Kovalenko VM, Kornatskiy VM, Manoylenko TS. Dinamika stanu zdorov’ya narodu Ukrayini ta regionalni osoblivosti. Analitichno-statistichniy posibnik. Kiyiv; 2012. 211 s. [in Ukrainian].
2.  Velkov VV. Novyie mezhdunarodnyie kriterii infarkta miokarda i vyisokochuvstvitelnyie troponinyi: novyie vozmozhnosti i novyie problemyi. Laboratorna diagnostika. 2013;64(2):59-71. [in Russian].
3. Soldatova OV, Kubyishkin AV, Ushakov AV. Dinamika urovnya provospalitelnyih tsitokinov pri razlichnyih variantah techeniya ostrogo infarkta miokarda. Biulleten Sibirskoi mieditsyny. 2017;16(1):92-100. [in Russian].
4.  Lecour S, James RW. When are pro-inflammatory cytokines SAFE in heart failure? Eur Heart J. 2011;32 (6):680-5.
5. Govorun VM, Ivanov VT. Proteomika i peptidomika v fundamental’nyh i prikladnyh medicinskih issledovaniyah. Bioorg himiya. 2011;37(2):199- 215. [in Russian].
6. Pavlov SV, Burlaka KA. Suchasni molekulyarno-genetichni markeri v diagnostitsi ta skriningu efektivnosti provedenoyi terapiyi zahvoryuvan sertsevo-sudinnoyi sistemi. Vіsnik problem bіologіі ta midicini. 2018;2(144):49-55. [in Ukrainian].
7. Savic-Radojevic A, Pljesa-Ercegovac M, Matic M. Novel Biomarkers of Heart Failure. Advances in Clinical Chemistry. 2017;79:93-152.
8. Povstyaniy MYu, Sheyman BS, Osadcha OІ. Dinamіka toksometrichnih pokaznikіv u hvorih z tyazhkimi ta vkray tyazhkimi opіkami. Shpital’na hіrurgіya. 2001;4:53-6. [in Ukrainian].
9. Terehov SS, Smirnov IV, Shamborant OG. Sozdanie vysokoeffektivnogo fluorescentnogo zonda dlya izucheniya biodegradacii farmakologicheskih belkovyh preparatov in vivo. Acta naturae. 2014;6(4):58-63. [in Russian].
10. Dobrecov GE. Razvitie tehnicheskogo arsenala metoda fluorescentnyh zondov. Biofizika. 2013;58(5):741-7. [in Russian].
11.  Chizh NA, Babaeva AG, Sleta IV. Osobennosti razvitiya nekroza miokarda i remodelirovaniya serdca posle perevyazki koronarnoy arterii i lokal’noy kriodestrukcii levogo zheludochka. Problemy kriobiologii. 2011;21(3):321-9. [in Russian].
12. Chizh NA. Sposoby registracii elektrokardiogramm u krys dlya analiza variabel’nosti serdechnogo ritma. Eksperiment і klіn medicina. 2015;68(3):44-7. [in Russian].
13.  Cibul’kin NA. Sindrom udlinennogo intervala QT – osnovnye kliniko-patofiziologicheskie priznaki. Prakticheskaya medicina. 2012;60(5):98- 103. [in Russian].
14.  Murashko VV, Strutynskiy AV. Elektrokardiografiya. Moskva: MEDpressinform; 2004. 320 s. [in Russian].
15. Radchenko OM, Kondratyuk MO. Sindrom endogennoі іntoksikacіі v klіnіcі vnutrіshnіh hvorob (oglyad lіteraturi ta vlasnі sposterezhennya). Medichna gіdrologіya ta reabіlіtacіya. 2009;7(3):25-32. [in Ukrainian].
16. Medvedev BI, Kazachkova EA, Astahova TV, Popova AS. Diagnosticheskie i prognosticheskie vozmozhnosti ispol’zovaniya pokazateley molekul sredney massy i srednemolekulyarnyh peptidov syvorotki krovi pri vospalitel’nyh zabolevaniyah organov malogo taza zhenschin. Akusherstvo i ginekologiya. 1992;3(7):38-40. [in Russian].
17.  Korochkin IM. Opredelenie soderzhaniya srednemolekulyarnyh peptidov v krovi bol’nyh ostrym infarktom miokarda. Lab delo. 1988;(9):15- 21. [in Russian].

«Bulletin of problems biology and medicine» Issue 1 Part 2 (149), 2019 year, 192-197 pages, index UDK 616.127-005.8-092.4:612.172.4:612.398.12

10.29254/2077-4214-2019-1-2-149-192-197